These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 25732110)

  • 1. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
    Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
    Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective expression of C20orf54 in esophageal dysplasia: a possible biomarker of esophageal carcinoma for early detection.
    Li M; Kong J; Wang L; Yan H; Liang W; Wang N; Zhao J
    World J Surg Oncol; 2022 May; 20(1):155. PubMed ID: 35549728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
    Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Peng J; Hu Q; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Wei W; Liu S; Wang H
    Diagn Pathol; 2013 Oct; 8():177. PubMed ID: 24152793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production.
    Togashi Y; Arao T; Kato H; Matsumoto K; Terashima M; Hayashi H; de Velasco MA; Fujita Y; Kimura H; Yasuda T; Shiozaki H; Nishio K
    Oncotarget; 2014 May; 5(10):2962-73. PubMed ID: 24930674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value.
    Guo Y; Wang C; Miao X; Chen S; Qian Y; Li G; Jiang Y
    Pathol Res Pract; 2017 Nov; 213(11):1400-1403. PubMed ID: 28941722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.
    Takemura K; Kawachi H; Eishi Y; Kitagaki K; Negi M; Kobayashi M; Uchida K; Inoue J; Inazawa J; Kawano T; Board PG
    Hum Pathol; 2014 Feb; 45(2):331-41. PubMed ID: 24342434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
    Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
    Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
    Wang JD; Ma J; Wang FY; Peng LB; Wang X; Shi SS; Ma HH; Lu ZF; Lu GM; Zhou XJ
    Dis Esophagus; 2013; 26(7):737-45. PubMed ID: 23317107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
    Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
    Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
    Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Liu Z; Yang T; Xu Z; Cao X
    Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
    Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
    Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
    Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
    Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray.
    Sang M; Gu L; Liu F; Lian Y; Yin D; Fan X; Ding C; Huang W; Liu S; Shan B
    Arch Med Res; 2016 Apr; 47(3):151-61. PubMed ID: 27362547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.